Dion Gisele Insider Trades

Insider Trading History

Track insider trading activity for Dion Gisele. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $49.8k 30,000 shares
Last Trade
Jul 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.2k 30,000 shares
$1.54
$1.66
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $11.1k 6,667 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.1k 6,667 shares
$3.61
$1.66
Cytek BioSciences
Cytek BioSciences CTKB
Director
Holding Value $131k 30,242 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$253k 30,242 shares
$8.38
$4.33
Inhibikase Therapeutics
Inhibikase Therapeutics IKT
Director
Holding Value $99.6k 60,000 shares
Last Trade
Sep 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.8k 60,000 shares
$0.95
$1.66
Cytek BioSciences
Cytek BioSciences CTKB
Director
Holding Value $112k 25,789 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$249k 25,789 shares
$9.67
$4.33
Cytek BioSciences
Cytek BioSciences CTKB
Director
Holding Value $21.7k 5,000 shares
Last Trade
Jul 22, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$4.33
Cytek BioSciences
Cytek BioSciences CTKB
Director
Holding Value $0 0 shares
Last Trade
Jul 22, 2021 Sale
No data
No data
$4.33

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up